# Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19

> **NCT04355533** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1056 (actual)

## Conditions studied

- COVID-19 Infection

## Interventions

- **BIOLOGICAL:** serology test
- **BIOLOGICAL:** nasopharyngeal swab
- **BIOLOGICAL:** rectal swab
- **BIOLOGICAL:** saliva sample

## Key facts

- **NCT ID:** NCT04355533
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-29
- **Primary completion:** 2022-05-20
- **Final completion:** 2022-05-24
- **Target enrollment:** 1056 (ACTUAL)
- **Last updated:** 2026-01-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04355533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04355533, "Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04355533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*